Christopher Garten

VP, Quality Assurance at Synthekine

Chris has served as Synthekine’s Vice President of Quality Assurance since January 2023, overseeing the development of the chemistry, manufacturing and controls (CMC) and clinical quality programs. Chris has 30 years of experience in product development and clinical quality support, leading to multiple market approvals. Prior to joining the Synthekine team, Chris was Vice President of Quality Assurance at PACT Pharma, where he led the build out of the PACT GxP Quality System supporting autologous TCR product. Prior to joining PACT, Chris held various senior leadership positions at Bellicum, Mesoblast, and GlaxoSmithKline (GSK) where he was integral to development, implementation and optimization of local and global quality management system (QMS) programs supporting clinical stage platforms. Chris holds a B.S. from the University of North Carolina-Greensboro.

Links

Previous companies

BlueSphere Bio logo
KBI Biopharma logo
Mesoblast logo
Merck logo
PACT Pharma logo
Bellicum Pharmaceuticals logo

Timeline

  • VP, Quality Assurance

    Current role